Total Payments
$892.07
2024 Payments
$275.09
Companies
12
Transactions
46
Medicare Patients
984
Medicare Billing
$95,236
Payment Breakdown by Category
Food & Beverage$892.07 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $892.07 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $303.88 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $173.59 | 9 | $0 (2024) |
| PFIZER INC. | $124.90 | 8 | $0 (2024) |
| ABBVIE INC. | $82.88 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $58.23 | 4 | $0 (2023) |
| Lilly USA, LLC | $37.80 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $27.72 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.33 | 1 | $0 (2022) |
| Boston Scientific Corporation | $19.07 | 1 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.54 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.09 | 16 | Novartis Pharmaceuticals Corporation ($70.63) |
| 2023 | $270.50 | 13 | Novo Nordisk Inc ($113.87) |
| 2022 | $175.78 | 11 | Novartis Pharmaceuticals Corporation ($49.64) |
| 2021 | $170.70 | 6 | Novo Nordisk Inc ($108.65) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.54 | General |
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Cardiovascular | ||||||
| 04/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/16/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $85.50 | General |
| 04/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 396 | 564 | $123,869 | $37,298 |
| 2022 | 12 | 467 | 706 | $148,797 | $46,682 |
| 2021 | 4 | 121 | 176 | $33,516 | $11,256 |
Total Patients
984
Total Services
1,446
Medicare Billing
$95,236
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 126 | $27,488 | $7,480 | 27.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 79 | $23,068 | $7,114 | 30.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 117 | $20,007 | $6,804 | 34.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 81 | 88 | $18,920 | $5,026 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $11,256 | $3,038 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 54 | 61 | $9,284 | $2,776 | 29.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 22 | $7,216 | $1,926 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $3,480 | $1,770 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $3,150 | $1,365 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 124 | 194 | $42,292 | $12,467 | 29.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 78 | 228 | $38,136 | $12,322 | 32.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 57 | 61 | $14,121 | $4,850 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 33 | $5,765 | $2,465 | 42.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 15 | $6,905 | $2,041 | 29.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 26 | $7,455 | $2,009 | 26.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $6,099 | $1,913 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 39 | 43 | $6,536 | $1,852 | 28.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,548 | $1,802 | 32.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $4,173 | $1,334 | 32.0% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 17 | 18 | $3,018 | $970.14 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $1,912 | $962.84 | 50.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 17 | 17 | $3,570 | $922.81 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,267 | $771.18 | 23.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 59 | 66 | $14,388 | $4,781 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 73 | $12,107 | $4,023 | 33.2% |
About Dr. Winston Plunkett, MD
Dr. Winston Plunkett, MD is a Family Medicine healthcare provider based in Cheraw, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1407351869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Winston Plunkett, MD has received a total of $892.07 in payments from pharmaceutical and medical device companies, with $275.09 received in 2024. These payments were reported across 46 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($892.07).
As a Medicare-enrolled provider, Plunkett has provided services to 984 Medicare beneficiaries, totaling 1,446 services with total Medicare billing of $95,236. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Cheraw, SC
- Active Since 03/28/2018
- Last Updated 12/08/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407351869
Products in Payments
- ELIQUIS (Drug) $123.24
- RYBELSUS (Drug) $108.65
- LEQVIO (Drug) $91.79
- ENTRESTO (Drug) $81.80
- Ozempic (Drug) $60.34
- XARELTO (Drug) $58.23
- Rybelsus (Drug) $49.39
- TRULICITY (Drug) $37.80
- VRAYLAR (Drug) $34.65
- UBRELVY (Drug) $34.36
- NURTEC ODT (Drug) $22.33
- WATCHMAN FLX (Device) $19.07
- PREVNAR 20 (Biological) $14.93
- CAMZYOS (Drug) $14.45
- QULIPTA (Drug) $13.87
- SOLIQUA 100/33 (Biological) $12.95
- Barostim Neo System (Device) $11.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cheraw
Dr. Travis Novinger, M.d, M.D
Family Medicine — Payments: $18,025
Family Medicine $18,025
John Mcleod, Md, MD
Family Medicine — Payments: $4,257
Family Medicine $4,257
Jeffrey Brock, M.d, M.D
Family Medicine — Payments: $2,083
Family Medicine $2,083
Cathryn Aliceaacosta, Md, MD
Family Medicine — Payments: $488.95
Family Medicine $488.95
Eric Mclaine, Do, DO
Family Medicine — Payments: $416.03
Family Medicine $416.03
Benjamin Hinman, M.d, M.D
Family Medicine — Payments: $310.50
Family Medicine $310.50